Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, ...

The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, ...

Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...

Manufactured by Eli Lilly and Company, Zepbound offers a new approach to managing OSA symptoms while also promoting significant weight loss. Zepbound is an injectable prescription medication ...

It is only available with a prescription and online pharmacies have certain checks to ensure you meet the criteria. Depending on your weight, some weight loss drugs can be approved for use ...

The negotiated prices of 15 Medicare Part D drugs, which include several blockbusters, will go into effect in 2027.

Announcement of the 15 medicines chosen for the second round of negotiations is one of the Biden administration’s final ...

The savings will likely be well received, given that KFF polling has found that over a quarter of Americans struggle to afford prescription ... class drug behind the brand-name weight-loss and ...

Getting healthy is a popular resolution and to meet goals, some people may turn to weight-loss drugs for help ... including those that are offering prescription drugs without a prescription ...